IONS IONIS PHARMACEUTICALS INC Product Launches 8-K Filing 2024 - FDA Approval Ionis Pharmaceuticals announced FDA approval for Tryngolza (olezarsen) to help reduce triglycerides in adults with familial chylomicronemia syndrome.Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC